DSPE-PEG-NHS, MW 600

DSPE-PEG-NHS, MW 600 is a PEG-modified phospholipid derivative that can be used to prepare liposomes. DSPE-PEG-NHS, MW 600 is commonly employed as a linker molecule for the surface modification of liposomes to confer targeting capabilities. DSPE-PEG-NHS, MW 600 can be used in the study of drug delivery[1][2].

Product Specifications

UNSPSC

12352200

Hazard Statement

H302-H315-H319-H335

Target

Liposome

Type

Biochemical Assay Reagents

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/dspe-peg-nhs-mw-600.html

Solubility

10 mM in DMSO

Smiles

CCCCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCCCC)=O)COP(OCCNC(OCCNC(CCC(ON1C(CCC1=O)=O)=O)=O)=O)(O)=O)=O.[n]

Molecular Weight

600 (Average)

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Zhao W, et al. DSPE-PEG Modification of α-Conotoxin TxID. Mar Drugs. 2019 Jun 8;17 (6) :342.|[2]Zhang X, et al. The study on brain targeting of the amphotericin B liposomes. J Drug Target. 2003 Feb;11 (2) :117-22.